We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$138M
AUM Growth
-$2.4M
Cap. Flow
-$7.83M
Cap. Flow %
-5.66%
Top 10 Hldgs %
37.97%
Holding
83
New
8
Increased
13
Reduced
37
Closed
3

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.73M
2
QCOM icon
Qualcomm
QCOM
+$2.42M
3
SRCLP
Stericycle, Inc
SRCLP
+$603K
4
AGN.PRA
Allergan plc
AGN.PRA
+$534K
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$417K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$6.48M
2
T icon
AT&T
T
+$2.34M
3
SRCL
Stericycle Inc
SRCL
+$2.16M
4
DE icon
Deere & Co
DE
+$1.36M
5
RAI
Reynolds American Inc
RAI
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 21.02%
2 Healthcare 19.72%
3 Financials 15.92%
4 Industrials 9.26%
5 Communication Services 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$161B
$2.62M 1.9%
38,615
+2,360
+7% +$166K
EMR icon
27
Emerson Electric
EMR
$82.9B
$2.49M 1.8%
41,565
-120
-0.3% -$7.16K
QCOM icon
28
Qualcomm
QCOM
$176B
$2.39M 1.73%
+41,645
New +$2.42M
CI icon
29
Cigna
CI
$76.6B
$2.17M 1.57%
14,835
-1,035
-7% -$153K
BCE icon
30
BCE
BCE
$19.9B
$1.93M 1.39%
43,516
-101
-0.2% -$4.45K
EFA icon
31
iShares MSCI EAFE ETF
EFA
$76.4B
$1.77M 1.28%
28,470
+6,900
+32% +$417K
SRCLP
32
DELISTED
Stericycle, Inc
SRCLP
$1.55M 1.12%
21,800
+8,800
+68% +$603K
MDT icon
33
Medtronic
MDT
$107B
$1.51M 1.09%
18,723
-660
-3% -$51.6K
AGN.PRA
34
DELISTED
Allergan plc
AGN.PRA
$1.49M 1.08%
1,762
+645
+58% +$534K
XOM icon
35
ExxonMobil
XOM
$651B
$1.41M 1.02%
17,247
– –
V icon
36
Visa
V
$677B
$1.32M 0.96%
14,900
-925
-6% -$79.6K
FTV icon
37
Fortive
FTV
$19B
$1.09M 0.79%
28,820
-1,129
-4% -$40.5K
NVO
38
Novo Nordisk
NVO
$216B
$833K 0.6%
48,598
– –
EEM icon
39
iShares MSCI Emerging Markets ETF
EEM
$28B
$820K 0.59%
20,812
– –
VFC icon
40
VF Corp
VFC
$6.68B
$811K 0.59%
15,677
-637
-4% -$31.4K
SHW icon
41
Sherwin-Williams
SHW
$78.3B
$774K 0.56%
7,482
– –
MSFT icon
42
Microsoft
MSFT
$2.84T
$766K 0.55%
11,634
– –
SLB icon
43
SLB Ltd
SLB
$77.8B
$570K 0.41%
7,300
-1,000
-12% -$81.8K
ORCL icon
44
Oracle
ORCL
$331B
$557K 0.4%
12,490
-250
-2% -$10.4K
BIVV
45
DELISTED
Bioverativ Inc. Common Stock
BIVV
$447K 0.32%
+8,212
New +$404K
ETN icon
46
Eaton
ETN
$157B
$433K 0.31%
5,845
– –
JNJ icon
47
Johnson & Johnson
JNJ
$635B
$352K 0.25%
2,823
-400
-12% -$47.8K
ABBV icon
48
AbbVie
ABBV
$458B
$350K 0.25%
5,370
-140
-3% -$8.8K
CBU icon
49
Community Bank
CBU
$3.53B
$312K 0.23%
5,667
– –
T icon
50
AT&T
T
$165B
$309K 0.22%
9,851
-74,395
-88% -$2.34M
1
2
3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q1 2017 Portfolio in Review

As of Q1 2017, Lipe & Dalton held 83 positions worth $138M, down 1.7% from $141M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton withdrew a net $7.83M in Q1 2017, closing 3 positions and reducing 37 holdings. Its most notable exit was JPMorgan Chase, an estimated $6.48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lipe & Dalton opened a new position in Qualcomm worth $2.39M.

  • Lipe & Dalton's largest Q1 2017 buy was Qualcomm: 41,645 shares worth $2.39M.
  • Lipe & Dalton added most to CVS Health in Q1 2017, an estimated $2.73M increase.
  • Lipe & Dalton's biggest Q1 2017 reduction was AT&T, cutting an estimated $2.34M.
  • Lipe & Dalton fully exited JPMorgan Chase in Q1 2017, selling an estimated $6.48M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $138M portfolio in Q1 2017.
  • Lipe & Dalton opened 8 new positions and closed 3 in Q1 2017.
  • Lipe & Dalton's portfolio value fell 1.7% quarter-over-quarter to $138M.

Based on Lipe & Dalton's 13F filing for Q1 2017, filed 8 May 2017.